PROTEONOMIX Stock

Stocks

PROT

US74371C2089

Pharmaceuticals

OTC Markets Traded
Market Closed - 11:40:30 2026-08-20 EDT 5-day change 1st Jan Change
0.000100 USD +25.00% Intraday chart for PROTEONOMIX 0.00% -
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0.1
Manager TitleAgeSince
Chief Executive Officer 60 -
Director of Finance/CFO 78 2012-08-01
Chief Tech/Sci/R&D Officer 58 2009-04-30
Director TitleAgeSince
Chairman 60 2010-01-19
Director/Board Member 58 2009-11-08
Director/Board Member 75 2009-12-29
Change 5-day change 1-year change 3-year change Capi.($)
+25.00%0.00% - - 0
-0.87%-3.94%+37.45%-2.73% 81.36B
-4.60%-18.13%+477.32%+27.55% 59.75B
+0.84%+4.44%-19.19%-35.11% 59.19B
+0.76%+3.53%+0.08%+36.18% 53.33B
+0.41%+1.88%+11.09%+171.67% 49.09B
+0.19%-0.03%+62.01%-16.23% 32.66B
-0.30%-0.57%+52.07%+100.03% 25.97B
-2.00%+9.52%+12.38%+218.34% 24.39B
+0.78%+0.47%+61.53%+123.40% 16.91B
Average +2.42%+0.14%+77.19%+69.23% 40.26B
Weighted average by Cap. -0.09%-1.01%+88.66%+47.64%
Logo PROTEONOMIX
Stromacel Inc. is a biotechnology company. The Company is a subsidiary of Proteonomix Inc. It offers technology in the field of cellular medicine to international clients. The Company intends to conduct phased human studies of its cellular materials in application to the treatment of cardiac and other diseases.
Employees
-
Date Price Change
  1. Stock Market
  2. Stocks
  3. PROT Stock